Reversible promoter methylation determines fluctuating expression of acute phase proteins
Abstract
Acute phase reactants (APRs) are secretory proteins exhibiting large expression changes in response to proinflammatory cytokines. Here we show that the expression pattern of a major APR, i.e. human C-reactive protein (CRP), is casually determined by DNMT3A and TET2-tuned promoter methylation status. CRP features a CpG-poor promoter with its CpG motifs located in binding sites of STAT3, C/EBP-β and NF-κB. These motifs are highly methylated at the resting state, but undergo STAT3- and NF-κB-dependent demethylation upon cytokine stimulation, leading to markedly enhanced recruitment of C/EBP-β that boosts CRP expression. Withdrawal of cytokines, by contrast, results in a rapid recovery of promoter methylation and termination of CRP induction. Further analysis suggests that reversible methylation also regulates the expression of highly inducible genes carrying CpG-poor promoters with APRs as representatives. Therefore, these CpG-poor promoters may evolve CpG-containing TF binding sites to harness dynamic methylation for prompt and reversible responses.
Data availability
Sequencing data have been deposited in GEO under accession code GSE146797
-
Bisulfite-Seq analysis of WGBS_Lib 11 derived from human liver cellsNCBI Gene Expression Omnibus, GSM916049.
-
liver_N3_BSNCBI Gene Expression Omnibus, GSM1716965.
-
Whole Genome Shotgun Bisulfite Sequencing of Fat Cells from Human STL003NCBI Gene Expression Omnibus, GSM1120331.
-
Whole Genome Shotgun Bisulfite Sequencing of Adrenal Cells from Human STL003NCBI Gene Expression Omnibus, GSM1120325.
-
Whole Genome Shotgun Bisulfite Sequencing of Aorta Cells from Human STL003NCBI Gene Expression Omnibus, GSM1120329.
-
Whole Genome Shotgun Bisulfite Sequencing of Esophagus Cells from Human STL003NCBI Gene Expression Omnibus, GSM983649.
-
Whole Genome Shotgun Bisulfite Sequencing of Gastric Cells from Human STL003NCBI Gene Expression Omnibus, GSM1120333.
-
Whole Genome Shotgun Bisulfite Sequencing of Lung Cells from Human STL002NCBI Gene Expression Omnibus, GSM983647.
-
Whole Genome Shotgun Bisulfite Sequencing of Ovary Cells from Human STL002NCBI Gene Expression Omnibus, GSM1120323.
-
Whole Genome Shotgun Bisulfite Sequencing of Psoas Cells from Human STL003NCBI Gene Expression Omnibus, GSM1010986.
-
Whole Genome Shotgun Bisulfite Sequencing of Right Atrium Cells from Human STL003NCBI Gene Expression Omnibus, GSM1120335.
-
Whole Genome Shotgun Bisulfite Sequencing of Sigmoid Colon Cells from Human STL001NCBI Gene Expression Omnibus, GSM983645.
-
Whole Genome Shotgun Bisulfite Sequencing of Spleen Cells from Human STL003NCBI Gene Expression Omnibus, GSM983652.
-
Whole Genome Shotgun Bisulfite Sequencing of Thymus Cells from Human STL001NCBI Gene Expression Omnibus, GSM1120322.
Article and author information
Author details
Funding
National Natural Science Foundation of China (31671339,31870767)
- Yi Wu
National Natural Science Foundation of China (31570749,31770819)
- Shang-Rong Ji
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: The experiments conformed to the Guide for the Care and Use of Laboratory Animals published by NIH, and were conducted according to the protocols approved by the Ethics Committee of Animal Experiments of Xi'an Jiaotong University and Lanzhou University.
Copyright
© 2020, Zhang et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,598
- views
-
- 191
- downloads
-
- 17
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Immunology and Inflammation
As a central hub for metabolism, the liver exhibits strong adaptability to maintain homeostasis in response to food fluctuations throughout evolution. However, the mechanisms governing this resilience remain incompletely understood. In this study, we identified Receptor interacting protein kinase 1 (RIPK1) in hepatocytes as a critical regulator in preserving hepatic homeostasis during metabolic challenges, such as short-term fasting or high-fat dieting. Our results demonstrated that hepatocyte-specific deficiency of RIPK1 sensitized the liver to short-term fasting-induced liver injury and hepatocyte apoptosis in both male and female mice. Despite being a common physiological stressor that typically does not induce liver inflammation, short-term fasting triggered hepatic inflammation and compensatory proliferation in hepatocyte-specific RIPK1-deficient (Ripk1-hepKO) mice. Transcriptomic analysis revealed that short-term fasting oriented the hepatic microenvironment into an inflammatory state in Ripk1-hepKO mice, with up-regulated expression of inflammation and immune cell recruitment-associated genes. Single-cell RNA sequencing further confirmed the altered cellular composition in the liver of Ripk1-hepKO mice during fasting, highlighting the increased recruitment of macrophages to the liver. Mechanically, our results indicated that ER stress was involved in fasting-induced liver injury in Ripk1-hepKO mice. Overall, our findings revealed the role of RIPK1 in maintaining liver homeostasis during metabolic fluctuations and shed light on the intricate interplay between cell death, inflammation, and metabolism.
-
- Genetics and Genomics
- Immunology and Inflammation
PIK3R1 encodes three regulatory subunits of class IA phosphoinositide 3-kinase (PI3K), each associating with any of three catalytic subunits, namely p110α, p110β, or p110δ. Constitutional PIK3R1 mutations cause diseases with a genotype-phenotype relationship not yet fully explained: heterozygous loss-of-function mutations cause SHORT syndrome, featuring insulin resistance and short stature attributed to reduced p110α function, while heterozygous activating mutations cause immunodeficiency, attributed to p110δ activation and known as APDS2. Surprisingly, APDS2 patients do not show features of p110α hyperactivation, but do commonly have SHORT syndrome-like features, suggesting p110α hypofunction. We sought to investigate this. In dermal fibroblasts from an APDS2 patient, we found no increased PI3K signalling, with p110δ expression markedly reduced. In preadipocytes, the APDS2 variant was potently dominant negative, associating with Irs1 and Irs2 but failing to heterodimerise with p110α. This attenuation of p110α signalling by a p110δ-activating PIK3R1 variant potentially explains co-incidence of gain-of-function and loss-of-function PIK3R1 phenotypes.